Chang‐Ki Min

Statistics

Publications

Citations

2.2K

H-Index

Active since

2002

Affiliations

The Catholic University of Korea Seoul St. Mary's Hospital(Current)

Catholic University of Korea

Seoul National University

Ewha Womans University

Seoul National University Hospital

Chang‐Ki Min is an author at The Catholic University of Korea Seoul St. Mary's Hospital specializing in medicine, multiple myeloma, and multiple myeloma treatment.

ORCID

Publications per year

2002–2025

Publications

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 354 citations · Full text

Medicine, Immunology, Oncology +17

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)

María‐Victoria Mateos, Shaji Kumar, Meletios Α. Dimopoulos et al. · Blood Cancer Journal · 2020 · 275 citations · Full text

Medicine, Hematology, Oncology +12

Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Andrew Spencer, Suzanne Lentzsch, Katja Weisel et al. · Haematologica · 2018 · 262 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

María‐Victoria Mateos, Pieter Sonneveld, Vânia Hungria et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 153 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

Jesús F. San Miguel, Joan Bladé, Ofer Shpilberg et al. · Blood · 2014 · 141 citations · Full text

Medicine, Immunology, Oncology +16

1–5 of 33